Ellagic acid and α-mangostin in oral gel formulations show anticancer, antiviral, and anti-inflammatory activities in vitro
Phytomedicine Plus · 2026-02 · 6 (1) · 100941
DOI: 10.1016/j.phyplu.2025.100941 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine Plus, 2026-02. Verfasst von Wipawee Nittayananta und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Nittayananta, W., Ekalaksananan, T., Chuerduangphui, J., Yupanqui, C. T., Netsomboon, K., & Pientong, C. (2026). Ellagic acid and α-mangostin in oral gel formulations show anticancer, antiviral, and anti-inflammatory activities in vitro. Phytomedicine Plus, 6(1), 100941. https://doi.org/10.1016/j.phyplu.2025.100941
Vancouver
Nittayananta W, Ekalaksananan T, Chuerduangphui J, Yupanqui CT, Netsomboon K, Pientong C. Ellagic acid and α-mangostin in oral gel formulations show anticancer, antiviral, and anti-inflammatory activities in vitro. Phytomedicine Plus. 2026;6(1):100941. doi:10.1016/j.phyplu.2025.100941
BibTeX
@article{Nittayananta2026,
author = {Nittayananta, Wipawee and Ekalaksananan, Tipaya and Chuerduangphui, Jureeporn and Yupanqui, Chutha Takahashi and Netsomboon, Kesinee and Pientong, Chamsai},
title = {Ellagic acid and α-mangostin in oral gel formulations show anticancer, antiviral, and anti-inflammatory activities in vitro},
journal = {Phytomedicine Plus},
year = {2026},
volume = {6},
number = {1},
pages = {100941},
doi = {10.1016/j.phyplu.2025.100941}
}
EUVIMED